Test Your Knowledge of Psoriasis Research From Fall Clinical Dermatology Conference 2023!
Do you remember the psoriasis research presented at Fall Clinical Dermatology Conference 2023? Test your knowledge now!
Dec 14, 2023
Search
Advertisement
MEETING BRIEF
Fall Clinical Dermatology Conference 2023: Psoriasis
The latest news from Fall Clinical Dermatology Conference 2023 on psoriasis, including abstracts, featured articles, and information about the conference.
Interleukin Inhibitors Highly Effective for Patients With Psoriasis
Interleukin Inhibitors Highly Effective for Patients With Psoriasis
April Armstrong, MD, MPH, spoke with Physician’s Weekly about the role of interleukin inhibitors, IL-17 and IL-23, in treating psoriasis.
From Agent to Agent, Interleukin Inhibitors Offer Distinct Benefits in Psoriasis
From Agent to Agent, Interleukin Inhibitors Offer Distinct Benefits in Psoriasis
The benefits of interleukin inhibitors vary by agent and include increased drug survival and earlier attainment of Psoriasis Area Severity Index scores.
Treating Patients of Color With Psoriasis Presents Many Challenges
Treating Patients of Color With Psoriasis Presents Many Challenges
Dermatologists must be knowledgeable about differences among people of color with psoriasis and to tailor their approach to diagnosis and treatment accordingly.
Addressing Educational & Research Gaps in Treating Psoriasis in Patients With All Skin Types
Addressing Educational & Research Gaps in Treating Psoriasis in Patients With All Skin Types
Educational and research gaps in treating plaque psoriasis in patients with skin of color can lead to delays in diagnosis and treatment.
Advertisement
PW QUIZ
Advertisement
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
